Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8592607
APP PUB NO 20130005987A1
SERIAL NO

13491190

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan, pharmaceutical compositions comprising them, their use in the treatment of various diseases and conditions, and processes for their preparation. In particular, the present invention relates the crystal modification 1 (polymorphic form F) of the mono-sodium salt of D-isoglutamyl-D-tryptophan.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APOTEX TECHNOLOGIES INCTORONTO ON M9L 1T9

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Leung-Toung, Regis Mississauga, CA 21 49
N′Zemba, Blaise Brampton, CA 1 0
Tam, Tim Fat Vaughan, CA 46 240
Wang, Yingsheng Toronto, CA 25 81
Yu, Lily Woodbridge, CA 10 3
Zhao, Yanqing Toronto, CA 28 69

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00